Quarterly report pursuant to Section 13 or 15(d)

Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details)

v3.24.1.1.u2
Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 558 363
Outstanding Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 558 350
Warrants to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 13